Influence of the Apelinergic System on Conduction Disorders in Patients after Myocardial Infarction.

Q/QRS ratio apelin-13 apelinergic system atrioventricular conduction disorders coronary artery disease elabela myocardial infarction

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
10 Dec 2023
Historique:
received: 26 10 2023
revised: 28 11 2023
accepted: 30 11 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

There is a growing body of evidence for an important role of the apelinergic system in the modulation of cardiovascular homeostasis. The aim of our study was to (1) examine the relationship between apelin serum concentration at index myocardial infarction (MI) and atrioventricular conduction disorders (AVCDs) at 12-month follow-up, and (2) investigate the association between initial apelin concentration and the novel marker of post-MI scar (Q/QRS ratio) at follow-up. In 84 patients with MI with complete revascularization, apelin peptide serum concentrations for apelin-13, apelin-17, elabela (ELA) and apelin receptor (APJ) were measured on day one of hospitalization; at 12-month follow-up, 54 of them underwent thorough examination that included 12-lead electrocardiography (ECG), Holter ECG monitoring and echocardiography. The mean age was 58.9 years. At 12-month follow-up, AVCDs were diagnosed in 21.4% of subjects, with AV first-degree block in 16.7% and sinoatrial arrest in 3.7%. ELA serum concentration at index MI correlated positively with the occurrence of AVCD ( The apelin peptide concentration during an acute phase of MI impacts the development of AVCD and the value of Q/QRS ratio in MI survivors.

Sections du résumé

BACKGROUND BACKGROUND
There is a growing body of evidence for an important role of the apelinergic system in the modulation of cardiovascular homeostasis. The aim of our study was to (1) examine the relationship between apelin serum concentration at index myocardial infarction (MI) and atrioventricular conduction disorders (AVCDs) at 12-month follow-up, and (2) investigate the association between initial apelin concentration and the novel marker of post-MI scar (Q/QRS ratio) at follow-up.
METHODS METHODS
In 84 patients with MI with complete revascularization, apelin peptide serum concentrations for apelin-13, apelin-17, elabela (ELA) and apelin receptor (APJ) were measured on day one of hospitalization; at 12-month follow-up, 54 of them underwent thorough examination that included 12-lead electrocardiography (ECG), Holter ECG monitoring and echocardiography.
RESULTS RESULTS
The mean age was 58.9 years. At 12-month follow-up, AVCDs were diagnosed in 21.4% of subjects, with AV first-degree block in 16.7% and sinoatrial arrest in 3.7%. ELA serum concentration at index MI correlated positively with the occurrence of AVCD (
CONCLUSIONS CONCLUSIONS
The apelin peptide concentration during an acute phase of MI impacts the development of AVCD and the value of Q/QRS ratio in MI survivors.

Identifiants

pubmed: 38137673
pii: jcm12247603
doi: 10.3390/jcm12247603
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Science and Higher Education
ID : SUBZ.E090.23.015

Auteurs

Rafał Wyderka (R)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.
Faculty of Medicine, Wrocław University of Science and Technology, 50-370 Wroclaw, Poland.

Dorota Diakowska (D)

Department of Basic Sciences, Faculty of Health Science, Wroclaw Medical University, Bartla 5, 51-618 Wroclaw, Poland.

Maria Łoboz-Rudnicka (M)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.

Jakub Mercik (J)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.

Michał Borger (M)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.
Department of Internal Nursing, Faculty of Health Science, Wroclaw Medical University, Bartla 5, 51-618 Wroclaw, Poland.

Łukasz Osuch (Ł)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.

Barbara Brzezińska (B)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.

Anna Leśków (A)

Department of Basic Sciences, Faculty of Health Science, Wroclaw Medical University, Bartla 5, 51-618 Wroclaw, Poland.

Małgorzata Krzystek-Korpacka (M)

Department of Medical Biochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland.

Joanna Jaroch (J)

Department of Cardiology, Tadeusz Marciniak Lower Silesia Specialist Hospital-Emergency Medicine Center, Fieldorf 2, 54-049 Wroclaw, Poland.
Faculty of Medicine, Wrocław University of Science and Technology, 50-370 Wroclaw, Poland.
Department of Internal Nursing, Faculty of Health Science, Wroclaw Medical University, Bartla 5, 51-618 Wroclaw, Poland.

Classifications MeSH